BR112015003281A2 - derivados de diazepinona úteis para o tratamento de síndrome x frágil, doença de parkinson ou por refluxo - Google Patents
derivados de diazepinona úteis para o tratamento de síndrome x frágil, doença de parkinson ou por refluxoInfo
- Publication number
- BR112015003281A2 BR112015003281A2 BR112015003281A BR112015003281A BR112015003281A2 BR 112015003281 A2 BR112015003281 A2 BR 112015003281A2 BR 112015003281 A BR112015003281 A BR 112015003281A BR 112015003281 A BR112015003281 A BR 112015003281A BR 112015003281 A2 BR112015003281 A2 BR 112015003281A2
- Authority
- BR
- Brazil
- Prior art keywords
- parkinson
- fragile
- syndrome
- reflux
- disease
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
resumo patente de invenção: "derivados de diazepinona úteis para o tratamento de síndrome x frágil, doença de parkinson ou por refluxo". a invenção refere-se ao composto de fórmula i (i) ou um sal, hidrato ou solvato do composto; assim como todos os estereoisômeros (incluindo diastereoisômeros), tautômeros e compostos isotopicamente rotulados (incluindo substituições de deutério); assim como porções inerentemente formadas (por exemplo, polimorfos, solvatos e/ou hidratos).do mesmo, em que os substituintes são tais como definidos no relatório; a sua preparação, a sua utilização como medicamento e a medicamentos que o compreendem.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1215033.0A GB201215033D0 (en) | 2012-08-23 | 2012-08-23 | Diazepinone derivatives |
| PCT/IB2013/056782 WO2014030128A1 (en) | 2012-08-23 | 2013-08-21 | Diazepinone derivatives useful for the treatment of fragile x syndrome, parkinsons or reflux disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112015003281A2 true BR112015003281A2 (pt) | 2017-07-04 |
| BR112015003281A8 BR112015003281A8 (pt) | 2018-01-16 |
Family
ID=47045285
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112015003281A BR112015003281A8 (pt) | 2012-08-23 | 2013-08-21 | derivados de diazepinona úteis para tratamento de síndrome x frágil, doença de parkinson ou por refluxo, seus usos, composição farmacêutica, e combinação |
Country Status (44)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201215033D0 (en) * | 2012-08-23 | 2012-10-10 | Novartis Ag | Diazepinone derivatives |
| WO2019025931A1 (en) | 2017-07-31 | 2019-02-07 | Novartis Ag | USE OF A MUSSEL FOR REDUCING THE USE OF COCAINE OR FOR PREVENTING A RECHUTE IN THE USE OF COCAINE |
| EA202191812A1 (ru) | 2019-01-29 | 2021-10-25 | Новартис Аг | ПРИМЕНЕНИЕ АНТАГОНИСТА mGluR5 ДЛЯ ЛЕЧЕНИЯ ТОЛЕРАНТНОСТИ К ОПИОИДНЫМ АНАЛЬГЕТИКАМ |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3853851A (en) * | 1972-01-26 | 1974-12-10 | Ciba Geigy Corp | Diazepinoisoquinolines |
| GB0128996D0 (en) | 2001-12-04 | 2002-01-23 | Novartis Ag | Organic compounds |
| US7507836B2 (en) * | 2003-03-26 | 2009-03-24 | Merck & Co. Inc. | Benzamide modulators of metabotropic glutamate receptors |
| GB0413605D0 (en) * | 2004-06-17 | 2004-07-21 | Addex Pharmaceuticals Sa | Novel compounds |
| TW200811157A (en) * | 2006-05-05 | 2008-03-01 | Astrazeneca Ab | mGluR5 modulators I |
| CU20090172A6 (es) | 2009-10-09 | 2011-10-05 | Facultad De Quimica Universidad De La Habana | Sistemas tricíclicos y tetracíclicos con actividad sobre el sistema nervioso central y vascular |
| US8772301B2 (en) * | 2009-12-18 | 2014-07-08 | Sunovion Pharmaceuticals, Inc. | Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof |
| JP6110787B2 (ja) | 2011-05-10 | 2017-04-05 | 協和発酵キリン株式会社 | ピリミドジアゼピノン化合物 |
| GB201215033D0 (en) | 2012-08-23 | 2012-10-10 | Novartis Ag | Diazepinone derivatives |
-
2012
- 2012-08-23 GB GBGB1215033.0A patent/GB201215033D0/en not_active Ceased
-
2013
- 2013-08-21 AU AU2013307239A patent/AU2013307239B2/en not_active Ceased
- 2013-08-21 EA EA201590415A patent/EA029493B1/ru not_active IP Right Cessation
- 2013-08-21 PT PT137836714T patent/PT2888259T/pt unknown
- 2013-08-21 AP AP2014008140A patent/AP2014008140A0/xx unknown
- 2013-08-21 BR BR112015003281A patent/BR112015003281A8/pt active Search and Examination
- 2013-08-21 NZ NZ703628A patent/NZ703628A/en not_active IP Right Cessation
- 2013-08-21 LT LTEP13783671.4T patent/LT2888259T/lt unknown
- 2013-08-21 SI SI201331027T patent/SI2888259T1/en unknown
- 2013-08-21 MA MA37849A patent/MA37849A1/fr unknown
- 2013-08-21 PE PE2015000245A patent/PE20150401A1/es active IP Right Grant
- 2013-08-21 DK DK13783671.4T patent/DK2888259T3/en active
- 2013-08-21 ES ES13783671.4T patent/ES2672737T3/es active Active
- 2013-08-21 TR TR2018/07174T patent/TR201807174T4/tr unknown
- 2013-08-21 NO NO13783671A patent/NO2888259T3/no unknown
- 2013-08-21 WO PCT/IB2013/056782 patent/WO2014030128A1/en active Application Filing
- 2013-08-21 EP EP13783671.4A patent/EP2888259B1/en active Active
- 2013-08-21 UA UAA201413654A patent/UA114326C2/uk unknown
- 2013-08-21 PL PL13783671T patent/PL2888259T3/pl unknown
- 2013-08-21 MX MX2015002367A patent/MX365253B/es active IP Right Grant
- 2013-08-21 CA CA2878564A patent/CA2878564C/en active Active
- 2013-08-21 JP JP2015527996A patent/JP6169699B2/ja not_active Expired - Fee Related
- 2013-08-21 HU HUE13783671A patent/HUE037971T2/hu unknown
- 2013-08-21 KR KR1020157003903A patent/KR102104149B1/ko active IP Right Grant
- 2013-08-21 RS RS20180581A patent/RS57231B1/sr unknown
- 2013-08-21 SG SG11201500068QA patent/SG11201500068QA/en unknown
- 2013-08-21 MY MYPI2014003502A patent/MY170103A/en unknown
- 2013-08-21 SG SG10201701333WA patent/SG10201701333WA/en unknown
- 2013-08-21 CN CN201380042195.XA patent/CN104520298B/zh not_active Expired - Fee Related
- 2013-08-22 TW TW102130096A patent/TWI616444B/zh not_active IP Right Cessation
- 2013-08-22 US US13/973,454 patent/US8853203B2/en active Active
- 2013-08-22 UY UY0001034986A patent/UY34986A/es unknown
- 2013-08-22 JO JOP/2013/0250A patent/JOP20130250B1/ar active
- 2013-08-23 AR ARP130102989A patent/AR092212A1/es not_active Application Discontinuation
-
2014
- 2014-08-19 US US14/462,813 patent/US9284331B2/en active Active
- 2014-12-18 ZA ZA2014/09345A patent/ZA201409345B/en unknown
- 2014-12-19 TN TN2014000528A patent/TN2014000528A1/fr unknown
-
2015
- 2015-02-02 IL IL237062A patent/IL237062A/en active IP Right Grant
- 2015-02-20 PH PH12015500373A patent/PH12015500373A1/en unknown
- 2015-02-20 CL CL2015000416A patent/CL2015000416A1/es unknown
- 2015-02-23 CU CUP2015000016A patent/CU20150016A7/es unknown
- 2015-02-23 GT GT201500039A patent/GT201500039A/es unknown
- 2015-02-23 CR CR20150092A patent/CR20150092A/es unknown
- 2015-07-02 HK HK15106284.5A patent/HK1206008A1/xx not_active IP Right Cessation
-
2016
- 2016-02-12 US US15/042,924 patent/US9650377B2/en active Active
-
2017
- 2017-04-28 US US15/581,642 patent/US20170305903A1/en not_active Abandoned
- 2017-06-28 JP JP2017125822A patent/JP2017226661A/ja not_active Withdrawn
-
2018
- 2018-05-29 HR HRP20180850TT patent/HRP20180850T1/hr unknown
- 2018-06-07 CY CY181100599T patent/CY1120728T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1119227T1 (el) | Παραγωγα πυριδινης ως ηπιοι αναστολεις της rock | |
| EA201200952A1 (ru) | Производные пиразина и их применение для лечения неврологических нарушений | |
| BR112015021983A8 (pt) | compostos heterocíclicos, composições e usos dos mesmos | |
| EA201200174A1 (ru) | Производные оксазина и их применение в качестве ингибиторов bace для лечения неврологических нарушений | |
| EA201490888A1 (ru) | Новые производные пурина и их применение для лечения заболевания | |
| CY1112429T1 (el) | Υποκατεστημενα παραγωγα σουλφοναμιδιου | |
| MY182403A (en) | Dihydropyrimidine compounds and their application in pharmaceuticals | |
| MX2016006564A (es) | Compuestos dihidropirimidina y su aplicacion en productos farmaceuticos. | |
| UA113051C2 (xx) | Гетероциклічні похідні та їх застосування у лікуванні неврологічних розладів | |
| BR112015000399A2 (pt) | derivados de pirazolil pirimidina | |
| BR112014018702A8 (pt) | Composto, cristal, inibidor, medicamento, composição farmacêutica, e, uso de um composto ou sal | |
| EA201391029A1 (ru) | Производные оксазина и их применение при лечении неврологических нарушений | |
| BR112012010186B8 (pt) | derivados de heteroarila contendo n como inibidores de quinase jak3 e composição farmacêutica compreendendo os mesmos | |
| EA201001683A1 (ru) | Производные фенил- или пиридинилзамещенных индазолов | |
| BR112015020772A2 (pt) | compostos de pirimidina e piridina e seu uso | |
| UY33380A (es) | Formulaciones farmacéuticas que contienen derivados de 1-(b(beta)-d-glucopiranosilo) y sus usos | |
| BR112012029647A2 (pt) | novos derivados de pirimidinas | |
| UA115868C2 (uk) | Гетероциклічні сполуки, лікарські засоби, які містять зазначені сполуки, їх застосування і способи їх одержання | |
| EA201200471A1 (ru) | Простые эфирные производные бициклических гетероарилов | |
| UA109290C2 (uk) | Спільні кристали і солі інгібіторів ccr3 | |
| EA201692270A1 (ru) | Производные нафтиридиндиона | |
| BR112014008783A2 (pt) | compostos para o tratamento e profilaxia da doença causada por vírus sincicial respiratório | |
| BR112017021631A2 (pt) | composto, composição farmacêutica, combinação farmacêutica, método de tratamento, uso de um composto e processo para preparação de dito composto | |
| UA87284C2 (ru) | Соединения фенилпиридилпиперазина, способ их получения и фармацевтическая композиция, которая их содержит | |
| BR112015003281A2 (pt) | derivados de diazepinona úteis para o tratamento de síndrome x frágil, doença de parkinson ou por refluxo |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B11D | Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time |